Spago Nanomedical AB (publ) (SPAGO.ST)

SEK 0.19

(-1.57%)

Eps Summary of Spago Nanomedical AB (publ)

  • Spago Nanomedical AB (publ)'s latest annual eps in 2023 was -0.43 SEK , up 27.12% from previous year.
  • Spago Nanomedical AB (publ)'s latest quarterly eps in 2024 Q2 was -0.03 SEK , up 10.34% from previous quarter.
  • Spago Nanomedical AB (publ) reported an annual eps of -0.59 SEK in 2022, up 36.56% from previous year.
  • Spago Nanomedical AB (publ) reported an annual eps of -0.93 SEK in 2021, down -43.08% from previous year.
  • Spago Nanomedical AB (publ) reported a quarterly eps of -0.03 SEK for 2024 Q2, up 10.34% from previous quarter.
  • Spago Nanomedical AB (publ) reported a quarterly eps of -0.08 SEK for 2023 Q2, up 44.93% from previous quarter.

Annual Eps Chart of Spago Nanomedical AB (publ) (2023 - 2011)

Historical Annual Eps of Spago Nanomedical AB (publ) (2023 - 2011)

Year Eps Eps Growth
2023 -0.43 SEK 27.12%
2022 -0.59 SEK 36.56%
2021 -0.93 SEK -43.08%
2020 -0.65 SEK 27.78%
2019 -0.90 SEK -80.0%
2018 -0.50 SEK 46.24%
2017 -0.93 SEK -9.41%
2016 -0.85 SEK 15.84%
2015 -1.01 SEK 21.71%
2014 -1.29 SEK -0.78%
2013 -1.28 SEK 82.3%
2012 -7.23 SEK -137.05%
2011 -3.05 SEK 0.0%

Peer Eps Comparison of Spago Nanomedical AB (publ)

Name Eps Eps Difference
Simris Alg AB (publ) -0.16 SEK -168.75%
Vicore Pharma Holding AB (publ) -3.22 SEK 86.646%
Xbrane Biopharma AB (publ) -1.27 SEK 66.142%
Xintela AB (publ) -0.13 SEK -230.769%
Active Biotech AB (publ) -0.17 SEK -152.941%
Amniotics AB (publ) -0.01 SEK -3809.091%
Asarina Pharma AB (publ) -0.57 SEK 24.561%
BioArctic AB (publ) 2.60 SEK 116.538%
Calliditas Therapeutics AB (publ) -8.69 SEK 95.052%
Camurus AB (publ) 7.78 SEK 105.527%
Cantargia AB (publ) -1.65 SEK 73.939%
Scandinavian ChemoTech AB (publ) -1.13 SEK 61.947%
CombiGene AB (publ) -1.80 SEK 76.111%
Diamyd Medical AB (publ) -1.60 SEK 73.125%
Elicera Therapeutics AB (publ) -0.83 SEK 48.193%
Genovis AB (publ.) 0.94 SEK 145.745%
Guard Therapeutics International AB (publ) -11.26 SEK 96.181%
Mendus AB (publ) -4.40 SEK 90.227%
Isofol Medical AB (publ) -0.23 SEK -86.957%
Intervacc AB (publ) -1.69 SEK 74.556%
Kancera AB (publ) -0.80 SEK 46.25%
Karolinska Development AB (publ) 0.02 SEK 2250.0%
LIDDS AB (publ) -0.63 SEK 31.746%
Lipum AB (publ) -4.45 SEK 90.337%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -126.316%
Magle Chemoswed Holding AB (publ) 1.13 SEK 138.053%
NextCell Pharma AB -1.03 SEK 58.252%
OncoZenge AB (publ) -1.36 SEK 68.382%
Saniona AB (publ) -1.29 SEK 66.667%
Xspray Pharma AB (publ) -6.76 SEK 93.639%
Ziccum AB (publ) -1.54 SEK 72.078%
Modus Therapeutics Holding AB (publ) -1.01 SEK 57.426%
Alligator Bioscience AB (publ) -0.55 SEK 21.818%
Sprint Bioscience AB (publ) -0.01 SEK -6725.397%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -95.455%
Corline Biomedical AB -0.08 SEK -410.689%
IRLAB Therapeutics AB (publ) -3.43 SEK 87.464%
Bio-Works Technologies AB (publ) -1.57 SEK 72.611%
Aptahem AB (publ) -0.05 SEK -790.269%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 95.678%
Fluicell AB (publ) -0.24 SEK -79.167%
Biovica International AB (publ) -2.14 SEK 79.907%
AcouSort AB (publ) -1.29 SEK 66.667%
Abliva AB (publ) -0.09 SEK -375.664%
Egetis Therapeutics AB (publ) -1.27 SEK 66.142%
2cureX AB (publ) -1.85 SEK 76.757%
I-Tech AB 1.70 SEK 125.294%
Hansa Biopharma AB (publ) -15.83 SEK 97.284%
Cyxone AB (publ) -0.22 SEK -95.455%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 78.283%
Biosergen AB -0.60 SEK 28.333%
Nanologica AB (publ) -2.05 SEK 79.024%
SynAct Pharma AB -6.64 SEK 93.524%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -65.385%
BioInvent International AB (publ) -5.02 SEK 91.434%
Stayble Therapeutics AB (publ) -0.92 SEK 53.261%
Alzinova AB (publ) -0.41 SEK -4.878%
Oncopeptides AB (publ) -1.96 SEK 78.061%
Pila Pharma AB (publ) -0.47 SEK 8.511%
Ascelia Pharma AB (publ) -3.24 SEK 86.728%
Diagonal Bio AB (publ) -0.32 SEK -34.375%